Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers

PHASE4CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 21, 2023

Primary Completion Date

April 5, 2024

Study Completion Date

April 5, 2024

Conditions
Dry EyeDry Eye, EvaporativeDry Eye DiseaseEvaporative Dry EyeEvaporative Dry Eye DiseaseKerato Conjunctivitis Sicca
Interventions
DRUG

Miebo

Subjects will be instructed to use the Miebo eye drop four times per day in both eyes during their participation in clinical trial. The subjects will be required to remove their contact lenses prior to instillation of the Miebo eye drop and must wait 30 minutes before reinserting their contact lenses.

Trial Locations (1)

92037

Gordon Schanzlin New Vision Institute, San Diego

All Listed Sponsors
lead

Gordon Schanzlin New Vision

OTHER

NCT06176651 - Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers | Biotech Hunter | Biotech Hunter